Recent Patents on Cardiovascular Drug Discovery

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase

Volume:1   Issue: 2
Pp: 129-139
Nangaku Nangaku, Ichiro Kojima, Tetsuhiro Tanaka, Takamoto Ohse, Hideki Kato and Fujita Fujita
DOI: 10.2174/157489006777442522

Potential Applications of RNA Interference-Based Therapeutics in the Treatment of Cardiovascular Disease

Volume:1   Issue: 2
Pp: 141-149
Ali Hassan
DOI: 10.2174/157489006777442540

Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches

Volume:1   Issue: 2
Pp: 151-159
Reiko Inagi
DOI: 10.2174/157489006777442450

99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review

Volume:1   Issue: 2
Pp: 161-166
Tohoru Takeda, Jin Wu and Thet-Thet-Lwin
DOI: 10.2174/157489006777442496

Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications

Volume:1   Issue: 2
Pp: 167-175
Zia A. Khan and Subrata Chakrabarti
DOI: 10.2174/157489006777442531

Vasopressin Receptor Antagonists in Heart Failure

Volume:1   Issue: 2
Pp: 177-184
Robert E. Hobbs and W. H. Wilson Tang
DOI: 10.2174/157489006777442513

Levosimendan: A Novel Agent in Heart Failure

Volume:1   Issue: 2
Pp: 185-191
Nikolas Koumallos, Charalambos Antoniades, Dimitris Tousoulis, Cheerag Shirodaria and Christodoulos Stefanadis
DOI: 10.2174/157489006777442487

Role of PPAR in Cardiovascular Diseases

Volume:1   Issue: 2
Pp: 193-209
Saibal K. Das and Ranjan Chakrabarti
DOI: 10.2174/157489006777442441

Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs

Volume:1   Issue: 2
Pp: 211-224
Gregory J. Chen and Reza Forough
DOI: 10.2174/157489006777442478

Patent Annotations

Volume:1   Issue: 2
Pp: 225-227

DOI: 10.2174/157489006777442504

Patent Selections promotion: free to download

Volume:1   Issue: 2
Pp: 229-231

DOI: 10.2174/157489006777442469